top of page
Browse by category
Search


First RYGB cases performed with Johnson & Johnson MedTech’s OTTAVA Robotic Surgical System
Johnson & Johnson MedTech has completed the first cases in the clinical trial for the OTTAVA Robotic Surgical System, the first clinical...


Virginia Tech neuroscientists to explore how obesity affects brain circuits involved in reward, motivation, and emotions
Virginia Tech neuroscientists at Fralin Biomedical Research Institute are part of a cross-disciplinary team that will explore how obesity...


Soleno Therapeutics launches VYKAT XR for patients with Prader-Willi syndrome
Soleno Therapeutics has launched VYKAT XR (diazoxide choline) extended-release tablets, the company’s treatment for hyperphagia in...


Pfizer to discontinue development oral GLP-1 receptor agonist Danuglipron
Pfizer has decided to discontinue development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist,...


New guidelines for managing obesity in children and adolescents
A new guideline to help healthcare providers manage obesity in children and adolescents takes a patient-centred approach, emphasising...


SYNT-101 once-daily oral treatment for obesity mimics RYGB
Syntis Bio has announced positive preclinical and first-in-human data for its lead candidate, SYNT-101, an investigational once-daily...
Browse by tag






bottom of page